Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Tunis Med ; 89(4): 364-8, 2011 Apr.
Article in French | MEDLINE | ID: mdl-21484687

ABSTRACT

AIM: To assess the method of tricuspid annular motion and tricuspid annular velocity in the study of the right ventricular function after inferior myocardial infarction. METHODS: 65 patients with myocardial infarction were studied prospectively. The infarction site was anterior in 30 cases and inferior in 35 cases. 9 patients with inferior infarctus had electrocardiographic signs of right ventricular infarction. 24 healthy individuals served as control patients. The standard echocardiography was completed by the analysis of systolic motion of the tricuspid annulus with the use of M-mode and the recording of tricuspid annular velocity with the use of pulsed-move tissue imaging. RESULTS: The tricuspid annular motion was significantly reduced in inferior myocardial infarction compared with that in healthy individuals (20 and 25 mm, p<0.001). The peak systolic velocity of the tricuspid annulus was significantly reduced in inferior myocardial infarction compared with that in healthy individuals and patients with anterior infarction (11.5; 15; 14 cm/s, p<0.001). In the group of patients with inferior infarction, the tricuspid annular motion was significantly lower in patients with right ventricular infarction than in patients without right ventricular infarction (16 and 13 mm, p<0.001). The patients with right ventricular infarction had also a significantly decreased peak systolic tricuspid annular velocity (11 and 1305cm/s, p<0.001), peak early diastolic velocity (9 and 12.5cm/s, p<0.001) and late diastolic velocity (14 and 18 cm/s, p<0.001). CONCLUSION: The method of recording the motion and velocity of tricuspid annulus is simple and can be used to assess right ventricular function in patients with inferior myocardial infarction.


Subject(s)
Myocardial Infarction/physiopathology , Tricuspid Valve/physiopathology , Ventricular Dysfunction, Right/diagnostic imaging , Ventricular Function, Right , Case-Control Studies , Echocardiography , Female , Humans , Male , Middle Aged , Myocardial Infarction/diagnostic imaging , Prospective Studies , Tricuspid Valve/diagnostic imaging
2.
Tunis Med ; 86(6): 584-90, 2008 Jun.
Article in French | MEDLINE | ID: mdl-19216453

ABSTRACT

BACKGROUND: diagnosis end treatment of heart diseases, physiopathologic changes in pregnancy. AIM: Pregnancy in woman with heart disease increases the risk of maternal and fetal complications. The aim of the study is to precise the physiopathologic, diagnostic, and therapeutic characteristics of heart diseases in pregnant woman. METHODS: Extensive electronic search of the relevant literature was carried out using Medline. Key words used were:pregnancy, heart disease, maternal outcome, fetal outcome, cardiac complications. RESULTS: Rheumatic heart disease represent the most common cardiopathy found in pregnant woman in our country. Regurgitant valvular diseases are often well tolerated with medical therapy. Severe aortic stenosis is associated with poor prognosis. The use of percutaneous mitral balloon valvuloplasty has transformed treatment of mitral stenosis in symptomatic patients.In developed countries, congenital heart diseases are the most common cause of cardiopathy in pregnant women. Left-to-right shunts are generally well tolerated. Patients with Eisenmenger syndrome should be advised against pregnancy. Obstructive form of hypertrophic cardiomyopathy is associated frequently with hemodynamic deterioration in pregnancy. Dilated cardiomyopathy is usually considered as a contraindication of pregnancy. In the absence of underlying structural heart disease, cardiac arrhythmia are uncommon in pregnancy and usually don't require pharmacological treatment. Drug therapy of arrhythmia in pregnant woman is limited by side effects on the fetus. The prenatal counsel is based on the assessment of maternofetal risk. The management of pregnant woman requires a multidisciplinary team for optimal maternal and fetal outcomes.


Subject(s)
Heart Diseases/diagnosis , Pregnancy Complications, Cardiovascular/diagnosis , Aortic Valve Stenosis/diagnosis , Cardiomyopathy, Hypertrophic/diagnosis , Female , Heart Defects, Congenital/diagnosis , Heart Diseases/physiopathology , Heart Diseases/therapy , Heart Valve Diseases/diagnosis , Humans , Interdisciplinary Communication , Mitral Valve Stenosis/diagnosis , Pregnancy , Pregnancy Complications, Cardiovascular/therapy , Pregnancy Outcome , Rheumatic Heart Disease/diagnosis , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...